Laboratorio Avi-Mex, S.A. de C.V.

Mexique

 
Quantité totale PI 12
Rang # Quantité totale PI 127 161
Note d'activité PI 1,7/5.0    8
Rang # Activité PI 114 725

Brevets

Marques

2 0
2 0
8 0
0
 
Dernier brevet 2025 - Viral-vector recombinant vaccine...
Premier brevet 2000 - Avian infectious bronchitis viru...

Derniers inventions, produits et services

2023 Invention Viral-vector recombinant vaccine against porcine epidemic diarrhoea. Described is a recombinant v...
2022 Invention Recombinant vaccine against covid-19 to produce cellular response in individuals with pre-existin...
2021 Invention Recombinant vaccine against covid-19 based on a paramyxovirus viral vector. An active or inactiv...
Invention Recombinant vaccine against covid-19 based on a paramyxovirus viral vector. Described is a recomb...
2020 Invention Recombinant vaccine against covid-19 in a viral vector. A live or inactivated recombinant vaccine...
2014 Invention Recombinant inactivated viral vector vaccine. A vaccine is described, comprising an inactivated ...
Invention Vaccine in a recombinant vector of avian adenovirus serotype 9. The invention relates to a recomb...
2011 Invention Recombinant vaccine against prrs in a viral vector. A live or inactivated recombinant vaccine is ...
2009 Invention Coccidiocide combination for veterinary use. A combination is described that has coccidiocidal ef...
2008 Invention Recombinant inactivated viral vector vaccine. A vaccine is described, comprising an inactivated v...
Invention Recombinant inactivated viral vector vaccine. A vaccine is described comprising an inactivated vi...
2000 Invention Avian infectious bronchitis virus serotype. Disclosed is an avian infectious bronchitis virus ser...